Waldenström's macroglobulinemia risk factors: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}}{{AE}}{{MGS}} | {{CMG}}{{AE}}{{MGS}} {{RAK}} | ||
==Overview== | ==Overview== |
Revision as of 20:07, 30 October 2018
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia risk factors On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia risk factors |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2] Roukoz A. Karam, M.D.[3]
Overview
Common risk factors in the development of Waldenström macroglobulinemia are monoclonal gammopathy of undetermined significance, heredity, hepatitis C, and autoimmune disorders.[1]
Risk Factors
Common risk factors in the development of Waldenström macroglobulinemia include:[1]
- Monoclonal gammopathy of undetermined significance (MGUS)
- Pre-existing monoclonal gammopathy of undetermined significance is the most common risk factor for the development of Waldenström's macroglobulinemia.
- Heredity
- Hepatitis C
- Patients with chronic hepatitis C infection are more likely to develop Waldenström macroglobulinemia than general population.
- Autoimmune Diseases
- Certain autoimmune diseases, such as sjögren syndrome, increase the risk of developing Waldenström macroglobulinemia.
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015